Showing results (141-150 of 186) with videos related to
Sort By:
Pageof 19
Clinicoeconomics and Outcomes Research : CEOR|September 13, 2016
Targeting improved patient outcomes using innovative product listing agreements: a survey of Canadian and international key opinion leadersMelissa Thompson, Chris Henshall, Louis P Garrison, et al.The American Journal of Managed Care|December 1, 2015
Private sector risk-sharing agreements in the United States: trends, barriers, and prospectsLouis P Garrison, Josh J Carlson, Preeti S Bajaj, et al.Scientific Reports|April 19, 2018
Projected effectiveness and added value of HIV vaccination campaigns in South Africa: A modeling studySimon de Montigny, Blythe J S Adamson, Benoît R Mâsse, et al.Vaccines|March 28, 2024
New Vaccine Platforms-Novel Dimensions of Economic and Societal Value and Their MeasurementPhilip O Buck, Dumingu Aparna Gomes, Ekkehard Beck, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013
Performance-based risk-sharing arrangements-good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing arrangements task forceLouis P Garrison, Adrian Towse, Andrew Briggs, et al.Advances in Therapy|December 20, 2024
An Access-Focused Patient-Centric Value Assessment Framework for Medication Formulary Decision-Making in Immune-Mediated Inflammatory DiseasesMin Yang, Manish Mittal, A Mark Fendrick, et al.Journal of Market Access & Health Policy|March 12, 2020
Understanding the global measurement of willingness to pay in healthJean A McDougall, Wesley E Furnback, Bruce C M Wang, et al.Journal of Opioid Management|December 5, 2017
Projecting the cost, utilization, and patient care impact of prescribing extended release non-abuse-deterrent opioids to chronic pain patientsMihran Ara Yenikomshian, Alan G White, Michael E Carson, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 14, 2018
Economic Analysis of Vaccination Programs: An ISPOR Good Practices for Outcomes Research Task Force ReportJosephine Mauskopf, Baudouin Standaert, Mark P Connolly, et al.Current Medical Research and Opinion|November 17, 2011
Exenatide BID Observational Study (ExOS): results for primary and secondary endpoints of a prospective research study to evaluate the clinical effectiveness of exenatide BID use in patients with type 2 diabetes in a real-world settingRichard M Bergenstal, Louis P Garrison, Lesley-Ann Miller, et al.Pageof 19